ClinicalTrials.gg
CompletedNCT06954779Updated May 2, 2025

Arginine Plaque Metabolism Pilot Clinical Study

A Phase 3 interventional study of Colgate Cavity Protection and TOM's Superior Sensitivity Relief Toothpaste in Plaque, Dental, sponsored by Colgate Palmolive. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-02.

Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Sep 2024, 2 years 1 month ago, and no results have been posted to the registry.
  • Registered 9 months after the study started (first participant enrolled Jul 2024, registered Apr 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 34 studies in Dental Plaque by Colgate Palmolive — 2 open to participants now, 3 under way, 3 of them phase 3. Dental Plaque · Colgate Palmolive.

Enrollment
29th of 34
20 · median 85
Started
2024
with 7 others
Phase 3
26 of 34
2 open now
Registered
29th of 34
by date

Among the 34 studies in Dental Plaque by Colgate Palmolive, this one is the 29th largest by enrollment, is one of 8 that started in 2024, is one of 26 in phase 3, and was the 29th registered.

Dental Plaque

353 studies on the registry are indexed under Dental Plaque; 60 are open to participants now.

Browse Dental Plaque studies →

Open to participants now

2 of the 34 studies in Dental Plaque by Colgate Palmolive are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Who these studies take

Of the 35 Dental Plaque studies recruiting now, 10 (29%) set no upper age limit and 20 (57%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Dental Plaque by Colgate Palmolive, or all of them as a file.
02

Study summary

Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.

03

Conditions studied

  • Plaque, Dental

Browse trials for

Keywords

  • saliva
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed Form.
  • Male and female subjects aged 18-70 years, inclusive.
  • Availability for the nine-week duration of the clinical research study.
  • Good general health based on the opinion of the study investigator
  • Good general health

Exclusion criteria

Exclusion Criteria:

  • Moderate and/or advanced periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study.
  • Five or more carious lesions requiring immediate care.
  • Concurrent participation in any other oral care clinical study or test panel.
  • Self-reported pregnant or lactating women.
  • Dental prophylaxis received in the past four weeks prior to baseline examinations
  • History of tobacco use-smoking, vaping and chewing tobacco
  • Presence of orthodontic bands, presence of partial removable dentures
  • Tumor(s) of the soft or hard tissues of the oral cavity
  • Use of antibiotics or stain inducing medications any time during the two month prior to entry into the study
  • Use of oral care products containing antimicrobials (Zn, Sn, CPC, triclosan, alcohol containing mouthwash, etc
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Test 1 toothpaste

    fluoride toothpaste

    Drug: Colgate Cavity Protection

  • Experimental
    Test 2 toothpaste

    non fluoride toothpaste

    Drug: TOM's Superior Sensitivity Relief Toothpaste

Interventions

06

What researchers measure

Primary outcomes

  1. Plaque collection

    Fasting plaque will be collected before and after a sucrose rinse for lactic acid analysis and ammonia production.The plaque pH of collected samples will also be measured to provide trend data.

    Time frame: baseline, week 3, week 4, week 6, week 7, week 8, week 9

Secondary outcomes

  1. Saliva collection

    Differences in the arginine concentration in saliva pre- and post-brushing with treatment. Differences in microbiome composition and activity

    Time frame: week 5 and week 9

07

Study locations

1 site
  • Volpe Clinical Center
    Piscataway, New Jersey 08854, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Sep 2024, 1 month.

Of 20 phase 3 interventional studies under Dental Plaque, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 4. This study's 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2025
First posted
May 2, 2025
StartActual
Jul 24, 2024
Primary completionActual
Sep 20, 2024
CompletionActual
Sep 20, 2024
Last update
May 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06954779
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
May 2, 2025
Start date
Jul 24, 2024
Primary completion
Sep 20, 2024
Completion
Sep 20, 2024
Last update
May 2, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion